An inhibitory role of the G-protein regulator AGS3 in mTOR-dependent macroautophagy

Benjamin Groves1, Hilde Abrahamsen, Heather Clingan

  • 1Department of Molecular, Cellular, and Developmental Biology, University of California Santa Barbara, Santa Barbara, California, United States of America.

Plos One
|February 4, 2010
PubMed

Insights

The protein AGS3 plays a dual role in macroautophagy (cellular recycling). While its overexpression can stimulate this process, endogenous AGS3 actually inhibits macroautophagy, particularly when its phosphorylation is reduced.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Autophagy Research

Background:

  • Macroautophagy is a fundamental cellular degradation process crucial for maintaining cellular homeostasis.
  • Dysregulation of macroautophagy is linked to various diseases, including cancer and neurodegenerative disorders.
  • The precise role of AGS3 in regulating macroautophagy has been unclear, with conflicting previous findings.

Purpose of the Study:

  • To elucidate the specific function of AGS3 in the regulation of macroautophagy.
  • To investigate the impact of AGS3 expression levels and phosphorylation status on macroautophagy.
  • To understand the molecular mechanisms by which AGS3 modulates macroautophagy.

Main Methods:

  • Investigated the effects of AGS3 overexpression and knockdown on macroautophagy.
  • Utilized mammalian target of rapamycin (mTOR)-dependent macroautophagy induction models.
  • Analyzed the phosphorylation status of AGS3 in response to macroautophagy induction.
  • Compared the effects of wild-type AGS3 and a non-phosphorylatable AGS3 mutant on macroautophagy.

Main Results:

  • Unexpectedly, knockdown of AGS3 induced macroautophagy, suggesting an endogenous inhibitory role.
  • AGS3 phosphorylation levels decreased upon induction of mTOR-dependent macroautophagy.
  • Overexpression of a non-phosphorylatable AGS3 mutant failed to enhance macroautophagy.
  • These findings indicate that AGS3 acts as an inhibitor of macroautophagy, modulated by its phosphorylation status.

Conclusions:

  • Endogenous AGS3 functions as an inhibitor of macroautophagy.
  • AGS3 phosphorylation is a key regulatory event in the modulation of macroautophagy.
  • The phosphorylation state of AGS3 influences its ability to regulate macroautophagy, offering potential therapeutic targets.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high affinity and are together...